Find the latest pharmaceutical market place for formulations enquiry about Repaglinide on PharmaCompass.com.

Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA11817]

University Multiprofile Hospital For Active Treatment "Saint George" EAD is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 6-Dec-2021.
1. Ranitidine (150 mg) Film-Coated Tablets. The required quantity is 48,000 units.
2. Papaverine (20 mg/ ml in 1 ml) Ampoules. The required quantity is 50,000 units.
3. Butylscopolamine (20 mg/ ml in 1 ml) Ampoules. The required quantity is 50,000 units.
4. Metoclopramide (5 mg/ ml in 2 ml) Ampoules. The required quantity is 60,000 units.
5. Ursodeoxycholic Acid (250 mg) Hard Capsules. The required quantity is 20,000 units.
6. Repaglinide (0.5 mg) Tablets. The required quantity is 9,000 units.
7. Pyridoxine (100 mg in 2 ml) Ampoules. The required quantity is 20,000 units.
8. Pyridoxine (25 mg) Tablets. The required quantity is 80,000 units.

Reply

08 Nov 2021

In-Licensing & Supply Request // Anti-diabetic products (Metformin, Gliclazide etc.) wanted for the U.K. [ENA0002...

A market leader in the sales of glucose monitors, in the United Kingdom, is looking to expand its product offering to include anti-diabetic medicines. They are urgently seeking partners who can provide products which are approved/approvable by the MHRA

Reply

15 Jun 2016